Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07245758Completed

Facial iD Customized Mandible Reconstruction Plates

Role: lead

NCT07221916Completed

Stryker's Surgeon iD Mandible Reconstruction Plates: A Retrospective Post Market Follow Up

Role: lead

NCT07245719Completed

Stryker Universal Midface and Upper-Face Fixation System: A Retrospective Post Market Follow Up

Role: lead

NCT07245810Active Not Recruiting

Stryker Facial iD Universal Plate Configurator: A Retrospective Post Market Follow Up

Role: lead

NCT05362370Recruiting

Stryker PEEK Customized Implant: A Prospective Post Market Follow Up to Evaluate Safety, Performance and Effectiveness

Role: lead

NCT04498026Not ApplicableEnrolling By Invitation

Adherus™ Dural Sealant in Spinal Procedures

Role: lead

All 6 trials loaded